BIOV~PAPILOCARE~OVOSICARE~LIBICARE GENERATE REVENUES NOW EUPro Health Care distributes these products and they can be bought online now. Revenues are currently flowing in EU.
BIOV agreement with Pro Health Care........includes 2 more products already generating revenues
Ovosicare and Libicare, Procare Health’s over-the-counter supplements to support fertility enhancement for late maternity or IVF processes and improve menopausal symptoms.
The vaccines, the vaccines.............those approvals will be our golden egg!!
Papilocare Clinical Trials EU started Oct 2015 and were completed 2019. See chart below
That's a ton of ....APPROVAL.....evidence for FDA to swallow!
Product already generating revenues in EU for a couple years now uhh would ya say..........
Here is the link for those interested in entire read,
please copy/paste link.... https://clinicaltrials.gov/ct2/show/NCT04002154
Go to
Brief Summary:
Phase II, exploratory, randomized, open, controlled and parallel groups clinical trial to evaluate the effectiveness of exploratory gel Papilocare in the repair of the cervico-vaginal mucosa with lesions caused by HPV. All the patients included in the study will be Randomized (1:1:1).
| Human Papilloma Virus InfectionHuman Papilloma VirusCervix Lesion | Device: Papilocare vaginal gel | Not Applicable |
Detailed Description:
Phase II, exploratory, randomized, open, controlled and parallel groups clinical trial to evaluate the effectiveness of exploratory gel Papilocare in the repair of the cervico-vaginal mucosa with lesions caused by HPV. All the patients included in the study will be Randomized (1:1:1) to Arm A (Papilocare schedule A), Arm B (Papilocare schedule B) and Arm C (usual clinical practice -without treatment-). Selection period of 1 month, followed by randomization and 6 months of treatment followed by a period of another 6 months without treatment. Patients will visit the site into a total of 5 visits throughout the study.
Go to
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 134 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Ensayo clnico, Aleatorizado, Abierto, de Grupos Paralelos y Con Grupo Control, Para Explorar la Eficacia Del Gel PAPILOCARE en la reparacin de la Mucosa crvico-vaginal Con Lesiones Causadas Por VPH (Ensayo Clnico PALOMA) |
| Actual Study Start Date : | October 19, 2015 |
| Actual Primary Completion Date : | July 31, 2018 |
| Actual Study Completion Date : | February 28, 2019 |